Contact Us
Platform
Phenotypic Screening
iPSC Differentiation
Disease Modeling
Products
Back
Products
Hepatocyte
Back
Hepatocyte
Hepatocyte WT
NAFLD PNPLA3
NAFLD TM6SF2
GSD1a
A1ATD
FH
Intestinal
Back
Intestinal
Organoid
Monolayer
Pancreatic
Back
Pancreatic
Pancreatic WT
MODY3 Diabetes
Neonatal Diabetes
About us
Back
About us
Management Team
News
Events
Resources
Careers
Contact
Contact Us
Leadership team of international experts in the areas of gene editing, stem cell differentiation and cell therapy development
Management team
Dr Chris Kirton
Chief Executive Officer
Professor Ludovic Vallier
Chief Scientific Officer
Richard Willock
Chief Business Officer
Advance your scientific discoveries with our tailored disease modeling products and services
Get in touch
Bespoke services
Leverage our robust gene editing process that delivers physiologically relevant disease models to advance your discoveries
Discover Gene Editing Services
Disease modeling products
We offer a collaborative partnership with our clients to deliver models in a timely and efficient manner
View Product Range
Copyright © 2023 Definigen
Privacy policy
Terms and Conditions
Designed and built by
Onespacemedia
